Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q2 2015 · 10-Q
Revenue$132.67M$132.67M+10.5% vs Q2 2014 Net Income$3.22M$3.22M−6.6% vs Q2 2014 EPS Diluted$0.12$0.12−7.7% vs Q2 2014 Gross Profit$15,666,000+14.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
Operating Cash Flowderived-$593,000N/M Margins · derivedGross margin11.8%+0.4 pt vs Q2 2014
Operating margin2.9%+0.3 pt vs Q2 2014
Net margin2.4%−0.4 pt vs Q2 2014
ended Nov 30, 2014 · filed Jan 9, 2015 · 40 d after period end